Clinicopathological characteristics of breast cancer patients from Northern Tanzania: common aspects of late stage presentation and triple negative breast cancer

Abstract

Purpose: Breast cancer (BC) is the second most common cancer among Tanzanian women. Oestrogen (ER), progesterone and human epidermal growth factor receptor 2 play major roles in prognosis and treatment but data for Tanzania are sparse. This study aimed to determine these patterns and histological types, tumour grading and staging of BC patients in northern Tanzania for a better understanding of BC in the Sub-Saharan African (SSA) setting. Methods:A cross-sectional study recorded newly diagnosed BC cases at Kilimanjaro Christian Medical Centre between October 2018 and March 2019. Receptor status, histological types and grade, clinical stage and socio-demographic were recorded and descriptive and bivariate analyses performed.Results: 116 patients were enrolled. Median age was 53 years, 71.6% were ≥45 years. The commonest molecular subtype was triple negative breast cancer (TNBC) (n = 33; 28.4%). One hundred and two (87.9%) patients had invasive ductal carcinoma (IDC), poorly differentiated tumours (60; 51.7%) and clinical stage III disease (62; 53.0%). ER negative tumours were associated with poorly differentiated histological grade (relative risk (RR): 1.34 (0.87-2.07)), tumour size > 5 cm (RR: 1.67 (0.33-8.35)) and IDC (RR: 3.35 (0.56-20.23)). Clinical stages III & IV (odds ratio (OR): 1.64 (0.63-4.24)) were associated with hormone receptor (HR) negative tumours and metastasis (OR: 1.60 (0.68-3.74)) with TNBC. 18% of the patients reported about first-degree relatives with BC.Conclusions: Most patients presented in advanced stages and TNBC in their menopause. HR negative tumours were associated with poor histological differentiation and IDC. The high percentage of positive family history of BC and the differences in receptor patterns compared to other parts of the world should urge further genetic research on BC in SSA.

PAM50 intrinsic subtypes, risk of recurrence score and breast cancer survival in HIV-positive and HIV-negative patients—a South African cohort study

“…Breast cancer diagnosis at advanced stage is another known predictor of poor survival [ 6 ]. In our cohort, advanced disease at presentation was associated with poor overall and disease-free survival, and 56.6% of our patients had an advanced (Stage III/ IV) disease on presentation; similar to patients in a study in Tanzania (53.2%) [ 23 ], while in a study in Rwanda, more than 75% of patients presented with advanced disease [ 26 ]. In contrast, in the United States, less than 20% of patients had advanced breast cancer at the time of diagnosis [ 24 ].…”

Assessment of the Surgical Oncology Case Volume Within the Public Sector in Tanzania

“… 21 Reviews of patients with breast cancer at Kilimanjaro Christina Medical Centre, however, showed that only 17% of patients with breast cancer present with stage IV disease, suggesting that there is a significant population of women with curable breast cancer unable to access potentially curative surgical care in Tanzania. 18 In addition, the high proportion of patients with prostate and esophageal cancers that underwent palliative surgery highlights the need to identify patients with cancer early when surgical resection is still an option. The high proportion of palliative cases for esophageal and prostate cancers is consistent with previous series from East Africa which describe frequent late-stage diagnosis when surgical treatment options are limited to palliation.…”

Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania

“…The median age in Tanzania is 18.2 compared to the US which has a median age of 38.5 [ 4 ]. Several studies found the mean age of breast cancer diagnosis in Tanzania to be 49–53 years [ 11 – 13 ]. We think that it is likely that women aged 19–24 may be less concerned or less encouraged to follow-up with further diagnostic testing than women in older age groups.…”